TCL Archive Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34% June 28, 2013
TCL Archive Provenge Prolonged Prostate Cancer Survival By Seven Months, Study Finds September 26, 2003
TCL Archive In Brief: New York Legislature Votes $240 Mil. Bond Issue For Roswell Park Construction; Kripke Honored April 25, 1992
TCL Archive FDA Approved More Than 50 New Indications For Cancer In 32 Months, Analysis Finds February 19, 2010
TCL Archive Fourteen Immunology RFPs Announced, NCI will Have Eight More Immunodiagnosis; $43 Million Budgeted September 6, 1974
